Abstract
In patients with progressive multiple sclerosis, the presence of active inflammation is associated with improved efficacy of anti-inflammatory therapies. However, the frequency of active inflammation in this patient population is unknown, and is the subject of a new study.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have